XLock BIOSCIENCES
  • Home
  • Science
  • Team
  • Development
  • News
    • Publications
    • Funding and Grants
    • Intellectual Property
    • Meetings and Conferences
  • Contact

INVITED REVIEWS AND BOOK CHAPTERS

7/22/2023

 
  1. Roy I, Getschman AE, Volkman BF and Dwinell MB. Exploiting agonist biased signaling of chemokines to target cancer. Mol Carcinog. (2017) 56 804-813.
  2. Shi Z, Mabuchi T, Riutta SJ, Peterson FC, Volkman BF and Hwang ST, The chemokine, CCL20, and its receptor, CCR6, in the pathogenesis and treatment of psoriasis and psoriatic arthritis (2023) Journal of Psoriasis and Psoriatic Arthritis, in press.

Comments are closed.
XLock Biosciences
XLock Biosciences
​662 South 94th Place

West Allis, WI 53214

A Milwaukee
Biopharmaceutical Company
  • Home
  • Science
  • Team
  • Development
  • News
    • Publications
    • Funding and Grants
    • Intellectual Property
    • Meetings and Conferences
  • Contact